GSK3B and diabetic kidney disease: Interestingly, GSK-3β was involved in both pathways (Supplementary Fig. 8a, b), and it has been described to play a nonignorable role in several diseases [35], including diabetic nephropathy and glomerular podocyte injury [18, 20].